MACC1 gene can help predict better treatment options for patients with Klatskin carci

[News]

Bile duct cancer is rare and is usually detected too late. Often only extensive liver surgery can help or, in rare cases, liver transplantation. But which patients will benefit from surgery and which will not, because their risk of cancer recurrence is too high? With the oncogene MACC1 as a biomarker, physicians for the first time have a tool to decide which treatment option is best for patients with Klatskin carcinoma, one type of bile duct cancer.

More... (http://www.news-medical.net/news/20150901/MACC1-gene-can-help-predict-better-treatment-options-for-patients-with-Klatskin-carcinoma.aspx)